Grace Wade is a Health Reporter at Knowledia. She specializes in a range of topics including medicine and healthcare, alternative medicine, public health, and mental health, with a particular focus on health news, drugs and medication, and wellness. Her work has been featured in Knowledia and New Scientist.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Grace Wade's coverage predominantly focuses on healthcare, pharmaceuticals, and scientific advancements. She frequently cites data in her articles, indicating a preference for evidence-based information.
Given the nature of her article titles and themes covered, Grace may be interested in pitches that offer access to experts involved in medical research or drug development related to mental health, neurology, and Covid-19. Offering access to new studies or clinical trials could also attract her attention.
Remember not to limit your outreach based on geographic focus as Grace's coverage does not seem restricted by location.
This information evolves through artificial intelligence and human feedback. Improve this profile .
The first randomised controlled trial of microdosing LSD as a treatment for ADHD found the psychedelic drug wasn't any more effective than a placebo in alleviating symptoms
GLP-1 drugs have revolutionised the treatment of obesity, but the very reason they are effective is also why it's vital to prioritise exercise when taking them
Low-intensity steady-state cardio has been touted as a way to lose weight and put less strain on your body while exercising. Science of exercise columnist Grace Wade looks into whether it works
The US has confirmed more than 480 measles cases across 19 states, the highest total since an outbreak in 2019 sickened more than 1200 people
As semaglutide-based weight loss treatments, such as Ozempic and Wegovy, become more popular, new side effects are emerging - and one is hair loss
A termination letter obtained by New Scientist reveals that the Trump administration has gutted the office that runs the country’s only nationwide survey on drug use and mental health
The artificial sweetener sucralose increases brain activity in regions involved in appetite, suggesting it makes people hungrier
A recently developed medication encourages people with cocaine use disorder to reduce their intake of the stimulant – a step towards the first approved drugs to treat the problem
It is harder for our bodies to absorb key nutrients from plant-based foods, so some vegans may be short on essential amino acids for healthy muscles and bones despite eating plenty of protein
A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like Ozempic and Wegovy. In phase III trials it significantly lowered blood sugar and bodyweight in people with type 2 diabetes
(833) 317-6278 
